Abstract 14409: Residual Risk of Ischemic Stroke Despite Anticoagulation in Patients Hospitalized with Atrial Fibrillation: Insights from the Get With The Guidelines-Atrial Fibrillation Program
Background: Oral anticoagulation (OAC) substantially reduces stroke risk in atrial fibrillation (AF), yet residual risk persists even among treated patients. Contemporary real-world data on this residual risk, its determinants, and longitudinal adherence to OAC are limited. Methods: We analyzed patients ≥65 ye...